EC
EcoR1 Capital’s Voyager Therapeutics VYGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Hold |
3,917,546
| – | – | 0.72% | 25 |
|
|
2025
Q1 | $13.2M | Hold |
3,917,546
| – | – | 0.79% | 22 |
|
|
2024
Q4 | $22.2M | Hold |
3,917,546
| – | – | 0.84% | 24 |
|
|
2024
Q3 | $22.9M | Hold |
3,917,546
| – | – | 0.78% | 30 |
|
|
2024
Q2 | $31M | Hold |
3,917,546
| – | – | 0.95% | 23 |
|
|
2024
Q1 | $36.5M | Buy |
3,917,546
+66,039
| +2% | +$615K | 0.92% | 24 |
|
|
2023
Q4 | $32.5M | Hold |
3,851,507
| – | – | 0.84% | 22 |
|
|
2023
Q3 | $29.8M | Hold |
3,851,507
| – | – | 1.01% | 19 |
|
|
2023
Q2 | $44.1M | Hold |
3,851,507
| – | – | 1.08% | 17 |
|
|
2023
Q1 | $29.7M | Sell |
3,851,507
-902,400
| -19% | -$6.96M | 0.96% | 16 |
|
|
2022
Q4 | $29M | Hold |
4,753,907
| – | – | 0.88% | 22 |
|
|
2022
Q3 | $28.1M | Hold |
4,753,907
| – | – | 0.83% | 26 |
|
|
2022
Q2 | $28.1M | Buy |
4,753,907
+1,196,400
| +34% | +$7.07M | 0.97% | 25 |
|
|
2022
Q1 | $27.1M | Hold |
3,557,507
| – | – | 0.85% | 26 |
|
|
2021
Q4 | $9.64M | Buy |
3,557,507
+3,111,515
| +698% | +$8.43M | 0.31% | 39 |
|
|
2021
Q3 | $1.17M | Buy |
+445,992
| New | +$1.17M | 0.04% | 60 |
|